LEXARIA BIOSCIENCE CORP. Disposal Group, Including Discontinued Operation, Revenue
LEXARIA BIOSCIENCE CORP. (LEXX) reported Disposal Group, Including Discontinued Operation, Revenue of $0 for the 9-month period ending 2022-05-31, per its 10-Q filed 2022-07-14.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2022-11-28
- LEXARIA BIOSCIENCE CORP. disposal group, including discontinued operation, revenue for the quarter ending 2022-05-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. disposal group, including discontinued operation, revenue for the quarter ending 2022-02-28 was $0.00.
- LEXARIA BIOSCIENCE CORP. disposal group, including discontinued operation, revenue for the quarter ending 2021-11-30 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. disposal group, including discontinued operation, revenue for the quarter ending 2021-08-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. disposal group, including discontinued operation, revenue for fiscal 2021 was $3.00K, a 95.70% decline from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. disposal group, including discontinued operation, revenue for fiscal 2020 was $69.75K.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|---|---|---|
| 2022-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | $0.00 derived: sum of 2 quarters · filed 2022-07-14 | $0.00 10-Q · filed 2022-07-14 | $0.00 derived: sum of 4 quarters · filed 2022-11-28 |
| 2022-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-04-11 | $0.00 10-Q · filed 2022-04-11 | $0.00 derived: sum of 3 quarters · filed 2022-11-28 | $0.00 derived: sum of 4 quarters · filed 2022-11-28 |
| 2021-11-30 | $0.00 10-Q · filed 2022-01-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-28 | $0.00 derived: sum of 3 quarters · filed 2022-11-28 | $0.00 derived: sum of 4 quarters · filed 2022-11-28 |
| 2021-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $0.00 derived: sum of 2 quarters · filed 2022-11-28 | $0.00 derived: sum of 3 quarters · filed 2022-11-28 | $3.00K 10-K · filed 2022-11-28 |
| 2021-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | $0.00 derived: sum of 2 quarters · filed 2022-07-14 | $3.00K 10-Q · filed 2022-07-14 | -$42.00K derived: sum of 4 quarters · filed 2022-07-14 |
| 2021-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-04-11 | $3.00K 10-Q · filed 2022-04-11 | -$42.00K derived: sum of 3 quarters · filed 2022-04-11 | $3.00K derived: sum of 4 quarters · filed 2022-04-11 |
| 2020-11-30 | $3.00K 10-Q · filed 2022-01-14 | -$42.00K derived: sum of 2 quarters · filed 2022-01-14 | $3.00K derived: sum of 3 quarters · filed 2022-01-14 | $21.00K derived: sum of 4 quarters · filed 2022-01-14 |
| 2020-08-31 | -$45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $0.00 derived: sum of 2 quarters · filed 2021-11-29 | $18.00K derived: sum of 3 quarters · filed 2021-11-29 | $69.75K 10-K · filed 2021-11-29 |
| 2020-05-31 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-15 | $63.00K derived: sum of 2 quarters · filed 2021-07-15 | $114.75K 10-Q · filed 2021-07-15 | |
| 2020-02-29 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | $69.75K 10-Q · filed 2021-04-14 | ||
| 2019-11-30 | $51.75K 10-Q · filed 2021-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |